Medicines are amongst the most widely used products on the planet
The average cost of developing a new candidate drug is £515 million
Only 10% of molecules make it to market due to high attrition rates
Potential pitfalls in drug development include severe side effects, delivery complications, or lack of intended efficacy
Medicinal chemists update drug design rules and tactics to maximize a molecule's success
Medicinal chemistry is an interdisciplinary field combining aspects of organic chemistry, physical chemistry, pharmacology, microbiology, biochemistry, and computational chemistry
It focuses on the discovery, design, synthesis, and interactions of pharmaceutical agents with the body
Mainly concerned with small organic molecules, both natural and synthetic
Compounds in clinical use are primarily small organic compounds
Other compounds used in medicine include organometallic compounds, biopharmaceuticals, and inorganic compounds
Chemotherapy is the therapeutic use of chemical agents to treat diseases
It involves administering cytotoxic drugs to destroy or inhibit the growth of malignant cells, commonly used in cancer treatment
Chemotherapy can be used alone or in conjunction with surgery or radiation
Discovery and Design in medicinal chemistry
A typical pharmacy contains about 2000 medications
Most medicines contain a single active ingredient, usually an organiccompound
Medicinal chemists aim to find compounds with potent effects on diseases and minimal side effects
Successful drugs must be selective, reach the correct cells, and react as intended
Sources of drugs
Herbs used historically can provide starting points for medicines, like quinine from cinchona tree for malaria
Marine chemistry is a promising source of drugs, with compounds like Bengamide A showing anti-tumor properties
Rainforests and venoms are rich sources of potential drugs, with plant species and snake venoms providing lead compounds
Microorganisms like bacteria and fungi have been sources of antibacterial drugs since World War II
Drug targets in the body
Main drug targets are macromolecules like nucleic acids (DNA, RNA) and proteins (enzymes, receptors)
Drugs bind to targets in regions called binding sites, interacting through intermolecular or covalent bonds
Lead compound in drug development
Lead compounds serve as prototypes for designing biologically active compounds
Analogues of lead compounds are synthesized to improve therapeutic properties or reduce side effects
Molecular modification involves changing functional groups and structure to enhance drug effectiveness
Computer-generated models of active compounds are matched with enzyme sites to identify target molecules for synthesis and testing
Drug Development Process
Drug discovery involves identifying potential new medicines through various scientific disciplines
Drug development phases include discovery, preclinical studies, clinical development, and market approval
Critical steps in the FDA drug development process include discovery, preclinical research, clinical development, FDA review, and post-market safety monitoring
Pre-clinical studies in drug development
Preclinical phase involves in vivo research to determine drug efficacy and safety
Researchers assess absorption, distribution, metabolism, excretion, benefits, side effects, and interactions with other treatments